Skip to main content
S&P 5007,718.60-0.38%DOW53,414.25-0.51%NASDAQ26,506.99-0.29%BTC$79,051.00-0.73%ETH$2,483.81+0.22%GOLD$4,476.600.00%OIL$91.480.00%
Smart Investors Daily
PF

NASDAQ · PFSA

Profusa, Inc. Common Stock

Healthcare · Medical - Equipment & Services

$2.72

Up+$0.10 (+3.82%)

Updated Sep 7, 2026, 3:28 PM

SID Score

5.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
7.48M
P/E ratio
-0.14
Dividend yield
0.00%
52-week range
$0.10 – $28.32
Volume
167.04K
Avg. volume
12.57M

Price performance

PFSA price history

1M range · 20 trading sessions · Daily adjusted prices

PFSA closed at $2.72 after 20 trading sessions, up 189.67% for the selected period.

Last close
$2.72
Period change
+189.67%
Period low
$0.94
Period high
$27.48
Daily close
View OHLC price history
PFSA OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 4, 2026$2.55$2.87$2.55$2.72167.04K
Sep 3, 2026$2.66$2.66$2.49$2.62148.3K
Sep 2, 2026$2.88$2.895$2.56$2.67203.34K
Sep 1, 2026$2.98$2.98$2.74$2.88224.04K
Aug 31, 2026$3.10$3.55$2.84$3.001.23M
Aug 28, 2026$4.10$4.13$2.74$2.93644.67K
Aug 27, 2026$4.23$4.76$4.10$4.24347.23K
Aug 26, 2026$4.49$4.501$4.1101$4.255291.03K
Aug 25, 2026$4.45$5.18$3.92$5.001.28M
Aug 24, 2026$5.26$5.6874$4.25$4.58469.02K
Aug 21, 2026$6.65$7.5365$5.2801$5.46647.69K
Aug 20, 2026$12.92$13.00$7.11$7.571.18M
Aug 19, 2026$15.93$17.58$11.71$13.571.46M
Aug 18, 2026$8.82$28.32$8.58$27.4853.54M
Aug 17, 2026$4.08$6.77$3.75$4.533.5M
Aug 14, 2026$3.6884$3.6884$3.4492$3.599221.27K
Aug 13, 2026$3.40$3.8024$3.2228$3.802450.44K
Aug 12, 2026$3.88$3.88$3.80$3.867.84K
Aug 11, 2026$3.80$3.9996$3.76$3.9412.04K
Aug 10, 2026$0.958$0.9843$0.9224$0.93938.83K

Latest PFSA news

The latest Smart Investors Daily articles mentioning PFSA.

Stock researchCompany · Overview

PFSA research

Overview

Company profile and research snapshot.

Company profile

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 31, 2026

Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement

Berkeley, CA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA) (the “Company”) announced that it has received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that on August 14, 2026, following the effectiveness of the Company’s 1-for-4 reverse stock split, the Company had less than the 500,000 publicly held shares required under Nasdaq Listing Rule 5550(a)(4) (the “Rule”). The Notice further stated that based on t

Benzinga · Aug 31, 2026

Profusa Regains Nasdaq Compliance

Profusa, Inc. (NASDAQ:PFSA) (the "Company") announced that it has received a letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating

Benzinga · Aug 21, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday's pre-market session. The company's market cap stands at $20.9 million. Jupiter Neurosciences (NASDAQ:JUNS)

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By